跳到正文
原文
STAT 主站· Mario Aguilar·· 21 天前AI 评分39

FDA和CMS努力避免监管瓶颈,促进AI医疗应用

STAT+: FDA, CMS scramble to avoid regulatory logjam as more states look to test AI in clinical settings

AI 导读

健康官员正试图解决联邦政府与各州在AI医疗技术监管上的重叠权限问题,以促进AI技术的应用。尽管特朗普政府已减轻了AI开发公司的监管负担并创造了新的支付方式,但AI在临床工作中的应用仍可能涉及FDA的监管,这引发了州级和联邦级监管机构之间的冲突。

正文

Officials worry that confusion over overlapping jurisdictions could stall health AI adoption

A sign for the Food And Drug Administration is seen outside of the headquarters. -- coverage from STAT
Sarah Silbiger/Getty Images

Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care; mental health chatbots; and consumer wearables. He’s also the co-author of the free, twice weekly STAT Health Tech newsletter. You can reach Mario on Signal at mariojoze.13.

Health officials hoping to boost adoption of artificial intelligence in health care have been moving behind the scenes to address brewing conflict between states and the federal government over the technology.

The Trump administration has sought to alleviate regulatory burden on companies developing health AI and created new ways to pay for the technology. But there remains a key problem: The federal government and states have overlapping jurisdiction over AI that performs clinical work, like writing prescriptions.

States regulate the practice of medicine and issue licenses to doctors and other clinicians. If AI performs these tasks without human supervision, that would likely push those products into the jurisdiction of the Food and Drug Administration, which regulates medical devices. 

STAT+ Exclusive Story

Already have an account? Log in

STAT+

STAT+

This article is exclusive to STAT+ subscribers

Unlock this article — and get additional analysis of the technologies disrupting health care — by subscribing to STAT+.

Already have an account? Log in

View All Plans

To read the rest of this story subscribe to STAT+.

Subscribe

  1. Health Tech Correspondent

    Mario covers technology in health care, including FDA regulation of artificial intelligence; how Medicare pays for health tech; the use of AI in clinical care; mental health chatbots; and consumer wearables. He’s also the co-author of the free, twice weekly STAT Health Tech newsletter. You can reach Mario on Signal at mariojoze.13.

来源:STAT 主站 · statnews.com